-+ 0.00%
-+ 0.00%
-+ 0.00%

VIRIDIAN THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TARGET PRICE TO $54 FROM $50

Reuters·11/05/2026 11:08:11

Please log in to view news